10X GENOMICS INC-CLASS A (TXG) Forecast, Price Target & Analyst Ratings

NASDAQ:TXG • US88025U1097

Current stock price

26.08 USD
+0.84 (+3.33%)
At close:
26 USD
-0.08 (-0.31%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for 10X GENOMICS INC-CLASS A (TXG).

Forecast Snapshot

Consensus Price Target

Price Target
$21.13
-18.99% Downside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
-$0.30
Revenue Estimate
147.98M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
72.73%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$21.13
Upside
-18.99%
From current price of $26.08 to mean target of $21.13, Based on 22 analyst forecasts
Low
$17.17
Median
$20.40
High
$26.25

Price Target Revisions

1 Month
3.94%
3 Months
16.37%

Price Target Summary

22 Wall Street analysts provided a forecast for the next 12 months for TXG. The average price target is 21.13 USD. This implies a price decrease of -18.99% is expected in the next year compared to the current price of 26.08.
The average price target has been revised upward by 16.37% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

TXG Current Analyst RatingTXG Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

TXG Historical Analyst RatingsTXG Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
72.73%
TXG was analyzed by 22 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about TXG.
In the previous month the buy percentage consensus was at a similar level.
TXG was analyzed by 22 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-14BarclaysMaintains Overweight -> Overweight
2026-04-07CitigroupMaintains Neutral -> Neutral
2026-03-31William BlairUpgrade Market Perform -> Outperform
2026-03-02StifelMaintains Buy -> Buy
2026-02-20UBSMaintains Neutral -> Neutral
2026-02-13TD CowenMaintains Hold -> Hold
2026-02-13StifelMaintains Buy -> Buy
2026-01-27Leerink PartnersMaintains Market Perform -> Market Perform
2026-01-07TD CowenMaintains Hold -> Hold
2025-12-22Canaccord GenuityMaintains Buy -> Buy
2025-12-15BarclaysMaintains Overweight -> Overweight
2025-12-11CitigroupDowngrade Buy -> Neutral
2025-12-02Morgan StanleyDowngrade Overweight -> Equal-Weight
2025-11-11Piper SandlerMaintains Neutral -> Neutral
2025-11-07UBSMaintains Neutral -> Neutral
2025-11-07BarclaysMaintains Overweight -> Overweight
2025-11-07JP MorganMaintains Neutral -> Neutral
2025-11-07Canaccord GenuityMaintains Buy -> Buy
2025-09-11Piper SandlerInitiate Neutral
2025-08-12Morgan StanleyMaintains Overweight -> Overweight
2025-08-08UBSMaintains Neutral -> Neutral
2025-08-08BarclaysMaintains Overweight -> Overweight
2025-06-26B of A SecuritiesMaintains Neutral -> Neutral
2025-06-24BarclaysMaintains Overweight -> Overweight
2025-05-19Morgan StanleyMaintains Overweight -> Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
-$0.30
Revenue Estimate
147.98M
Revenue Q2Q
-4.46%
EPS Q2Q
16.86%
Number of Analysts
18

Next Earnings Revisions

Revenue (1 Month)
0.14%
Revenue (3 Months)
2.27%
EPS (1 Month)
-0.81%
EPS (3 Months)
-3.88%

Next Earnings Summary

TXG is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is -0.3 USD and the consensus revenue estimate is 147.98M USD.
The next earnings revenue estimate has been revised upward by 2.27% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
TXG revenue by date.TXG revenue by date.
618.727M
19.82%		610.785M
-1.28%		642.823M
5.25%		619.75M
-3.59%		665.19M
7.33%		720.27M
8.28%		800.18M
11.09%		849.44M
6.16%		943.04M
11.02%		1.246B
32.13%
EBITDA
YoY % growth
TXG ebitda by date.TXG ebitda by date.
-159.437M
-11.86%		-156.58M
1.79%		-63.386M
59.52%		-87.655M
-38.29%		-45.491M
48.10%		-29.023M
36.20%		-18.887M
34.92%		N/AN/AN/A
EBIT
YoY % growth
TXG ebit by date.TXG ebit by date.
-194.949M
-16.11%		-192.459M
1.28%		-99.585M
48.26%		-133.98M
-34.54%		-106.994M
20.14%		-74.656M
30.22%		-59.691M
20.05%		-53.328M
10.66%		11.716M
121.97%		59.186M
405.17%
Operating Margin
TXG operating margin by date.TXG operating margin by date.
-31.51%-31.51%-15.49%-21.62%-16.08%-10.37%-7.46%-6.28%1.24%4.75%
EPS
YoY % growth
TXG eps by date.TXG eps by date.
-2.17
-47.62%		-1.52
29.95%		-0.43
71.71%		-0.98
-127.32%		-0.76
22.57%		-0.49
34.84%		0.22
145.05%		0.52
131.82%		0.86
66.67%		N/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		-0.30
16.86%		-0.26
-192.17%		-0.24
-8.56%		-0.18
-40.52%		-0.24
21.16%		-0.19
27.81%		-0.17
28.00%		-0.12
34.26%		-0.25
-7.00%		-0.16
13.26%		-0.13
23.65%		-0.05
60.75%
Revenue
Q2Q % growth		147.98M
-4.46%		149.85M
-13.34%		154.47M
3.67%		167.4M
0.83%		157.17M
6.21%		161.65M
7.87%		166.77M
7.96%		179.47M
7.21%		160.74M
2.27%		168.56M
4.27%		172.95M
3.71%		187.52M
4.49%
EBITDA
Q2Q % growth		-34.582M
14.62%		-24.462M
-317.19%		-23.412M
-332.91%		-13.11M
-161.67%		-24.894M
28.02%		-15.236M
37.72%		-21.782M
6.96%		-13.844M
-5.60%		-25.058M
-0.66%		-22.412M
-47.10%		-19.937M
8.47%		-12.08M
12.74%
EBIT
Q2Q % growth		-40.976M
15.56%		-35.829M
-683.31%		-32.331M
-2.50%		-25.057M
-67.71%		-35.802M
12.63%		-29.914M
16.51%		-26.111M
19.24%		-20.226M
19.28%		-44.182M
-23.41%		-27.654M
7.56%		-26.114M
-0.01%		-16.539M
18.23%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

TXG Yearly Revenue VS EstimatesTXG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
TXG Yearly EPS VS EstimatesTXG Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -1 -2 -3 -4 -5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-4.68%
EPS Next 5 Year
26.18%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
3.90%
Revenue Next 5 Year
5.75%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-3.59%
EBIT Next 5 Year
6.30%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

10X GENOMICS INC-CLASS A / TXG Forecast FAQ

What do analysts expect the price target to be for 10X GENOMICS INC-CLASS A (TXG)?

22 analysts have analysed TXG and the average price target is 21.13 USD. This implies a price decrease of -18.99% is expected in the next year compared to the current price of 26.08.

When does 10X GENOMICS INC-CLASS A (TXG) report earnings?

10X GENOMICS INC-CLASS A (TXG) will report earnings on 2026-05-07, after the market close.

What are the consensus estimates for TXG stock next earnings?

The consensus EPS estimate for the next earnings of 10X GENOMICS INC-CLASS A (TXG) is -0.3 USD and the consensus revenue estimate is 147.98M USD.

What is the number of analysts for TXG stock?

The number of analysts covering 10X GENOMICS INC-CLASS A (TXG) is 22.